Abstract
Nanoparticles (NPs) have recently attracted great attention as biomedical imaging agents. Many types of NPs have been investigated with combinations of various molecular targeting groups. In addition, multiplex imaging has been studied with NPs, including surface-enhanced Raman scattering (SERS) NPs. Single-photon emission computed tomography (SPECT) or positron emission tomography (PET) by molecularly targeted, radiolabeled NPs provides several benefits over usual imaging probes in the aspect of sensitivity and quantitation. In addition, multimodal imaging probes that are combinations of both radionuclide-based and non-radionuclide-based imaging approaches, such as optical imaging or magnetic resonance imaging (MRI), could be applied to next medical studies. Furthermore, molecularly targeted probes which could be identified by more than three imaging modalities are possible. In conclusion, nanotechnologies promise to extend the limitations of current molecular imaging techniques, and nanomedicine may play an important role in the future.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
W. Cai, X. Chen, Nanoplatforms for targeted molecular imaging in living subjects. Small 3, 1840–1854 (2007)
S.K. Sahoo, S. Parveen, J.J. Panda, The present and future of nanotechnology in human health care. Nanomedicine 3, 20–31 (2007)
R. Weissleder, U. Mahmood, Molecular imaging. Radiology 219, 316–333 (2001)
N. Beckmann, R. Kneuer, H.U. Gremlich, H. Karmouty-Quintana, F.X. Ble, M. Muller, In vivo mouse imaging and spectroscopy in drug discovery. NMR Biomed. 20, 154–185 (2007)
T.F. Massoud, S.S. Gambhir, Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17, 545–580 (2003)
D.E. Lee, H. Koo, I.C. Sun, J.H. Ryu, K. Kim, I.C. Kwon, Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem. Soc. Rev. 41, 2656–2672 (2012)
M.A. El-Sayed, Some interesting properties of metals confined in time and nanometer space of different shapes. Acc. Chem. Res. 34, 257–264 (2001)
L. Dykman, N. Khlebtsov, Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem. Soc. Rev. 41, 2256–2282 (2012)
N. Khlebtsov, V. Bogatyrev, L. Dykman, B. Khlebtsov, S. Staroverov, A. Shirokov et al., Analytical and theranostic applications of gold nanoparticles and multifunctional nanocomposites. Theranostics 3, 167–180 (2013)
N. Khlebtsov, L. Dykman, Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev. 40, 1647–1671 (2011)
M. Cheki, M. Moslehi, M. Assadi, Marvelous applications of quantum dots. Eur. Rev. Med. Pharmacol. Sci. 17, 1141–1148 (2013)
M. Bruchez Jr., M. Moronne, P. Gin, S. Weiss, A.P. Alivisatos, Semiconductor nanocrystals as fluorescent biological labels. Science 281, 2013–2016 (1998)
R. Hardman, A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ. Health Perspect. 114, 165–172 (2006)
X. Gao, Y. Cui, R.M. Levenson, L.W. Chung, S. Nie, In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22, 969–976 (2004)
Y. Ling, K. Wei, Y. Luo, X. Gao, S. Zhong, Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy. Biomaterials 32, 7139–7150 (2011)
E. Amstad, M. Textor, E. Reimhult, Stabilization and functionalization of iron oxide nanoparticles for biomedical applications. Nanoscale 3, 2819–2843 (2011)
N. Lewinski, V. Colvin, R. Drezek, Cytotoxicity of nanoparticles. Small 4, 26–49 (2008)
C.W. Jung, P. Jacobs, Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imaging 13, 661–674 (1995)
M. Longmire, P.L. Choyke, H. Kobayashi, Dendrimer-based contrast agents for molecular imaging. Curr. Top. Med. Chem. 8, 1180–1186 (2008)
H. Xu, C.A. Regino, Y. Koyama, Y. Hama, A.J. Gunn, M. Bernardo et al., Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjug. Chem. 18, 1474–1482 (2007)
T.A. Elbayoumi, V.P. Torchilin, Current trends in liposome research. Methods Mol. Biol. 605, 1–27 (2010)
A. Puri, K. Loomis, B. Smith, J.H. Lee, A. Yavlovich, E. Heldman et al., Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit. Rev. Ther. Drug Carrier Syst. 26, 523–580 (2009)
J.H. Senior, Fate and behavior of liposomes in vivo: a review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3, 123–193 (1987)
P. Laverman, M.G. Carstens, O.C. Boerman, E.T. Dams, W.J. Oyen, N. van Rooijen et al., Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J. Pharmacol. Exp. Ther. 298, 607–612 (2001)
P. Ehrlich, Croonian lecture: on immunity with special reference to cell life. Proc. R. Soc. Lond. 66, 424–448 (1899)
D. Colcher, G. Pavlinkova, G. Beresford, B.J. Booth, A. Choudhury, S.K. Batra, Pharmacokinetics and biodistribution of genetically-engineered antibodies. Q. J. Nucl. Med. 42, 225–241 (1998)
A.M. Scott, F.T. Lee, R. Jones, W. Hopkins, D. MacGregor, J.S. Cebon et al., A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake. Clin. Cancer Res. 11, 4810–4817 (2005)
E.N. Brody, L. Gold, Aptamers as therapeutic and diagnostic agents. J. Biotechnol. 74, 5–13 (2000)
K. Ohsawa, T. Kasamatsu, J. Nagashima, K. Hanawa, M. Kuwahara, H. Ozaki et al., Arginine-modified DNA aptamers that show enantioselective recognition of the dicarboxylic acid moiety of glutamic acid. Anal. Sci. 24, 167–172 (2008)
H. Tian, Combinatorial selection of RNA ligands for complex cellular targets: the RNA liagands-based proteomics. Mol. Cell. Proteomics 1, 99–103 (2002)
D.A. Daniels, H. Chen, B.J. Hicke, K.M. Swiderek, L. Gold, A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc. Natl. Acad. Sci. U.S.A. 100, 15416–15421 (2003)
D. Shangguan, Y. Li, Z. Tang, Z.C. Cao, H.W. Chen, P. Mallikaratchy et al., Aptamers evolved from live cells as effective molecular probes for cancer study. Proc. Natl. Acad. Sci. U.S.A. 103, 11838–11843 (2006)
A.D. Keefe, R.G. Schaub, Aptamers as candidate therapeutics for cardiovascular indications. Curr. Opin. Pharmacol. 8, 147–152 (2008)
T.C. Chu, K.Y. Twu, A.D. Ellington, M. Levy, Aptamer mediated siRNA delivery. Nucleic Acids Res. 34, e73 (2006)
P.E. Kish, Y. Tsume, P. Kijek, T.M. Lanigan, J.M. Hilfinger, B.J. Roessler, Bile acid-oligopeptide conjugates interact with DNA and facilitate transfection. Mol. Pharm. 4, 95–103 (2007)
R.M. Schiffelers, A. Ansari, J. Xu, Q. Zhou, Q. Tang, G. Storm et al., Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32, e149 (2004)
Y.L. Xie, W. Lu, X.G. Jiang, Improvement of cationic albumin conjugated pegylated nanoparticles holding NC-1900, a vasopressin fragment analog, in memory deficits induced by scopolamine in mice. Behav. Brain Res. 173, 76–84 (2006)
H. Hirabayashi, J. Fujisaki, Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents. Clin. Pharmacokinet. 42, 1319–1330 (2003)
S. Nie, S.R. Emory, Probing single molecules and single nanoparticles by surface-enhanced Raman scattering. Science 275, 1102–1106 (1997)
M. Vendrell, K.K. Maiti, K. Dhaliwal, Y.T. Chang, Surface-enhanced Raman scattering in cancer detection and imaging. Trends Biotechnol. 31, 249–257 (2013)
J.W. Chan, D.S. Taylor, T. Zwerdling, S.M. Lane, K. Ihara, T. Huser, Micro-Raman spectroscopy detects individual neoplastic and normal hematopoietic cells. Biophys. J. 90, 648–656 (2006)
J.W. Chan, D.S. Taylor, S.M. Lane, T. Zwerdling, J. Tuscano, T. Huser, Nondestructive identification of individual leukemia cells by laser trapping Raman spectroscopy. Anal. Chem. 80, 2180–2187 (2008)
K. Das, N. Stone, C. Kendall, C. Fowler, J. Christie-Brown, Raman spectroscopy of parathyroid tissue pathology. Lasers Med. Sci. 21, 192–197 (2006)
B.W. de Jong, T.C. Schut, K. Maquelin, T. van der Kwast, C.H. Bangma, D.J. Kok et al., Discrimination between nontumor bladder tissue and tumor by Raman spectroscopy. Anal. Chem. 78, 7761–7769 (2006)
M.V. Chowdary, K.K. Kumar, J. Kurien, S. Mathew, C.M. Krishna, Discrimination of normal, benign, and malignant breast tissues by Raman spectroscopy. Biopolymers 83, 556–569 (2006)
C.A. Lieber, S.K. Majumder, D.L. Ellis, D.D. Billheimer, A. Mahadevan-Jansen, In vivo nonmelanoma skin cancer diagnosis using Raman microspectroscopy. Lasers Surg. Med. 40, 461–467 (2008)
A. Nijssen, K. Maquelin, L.F. Santos, P.J. Caspers, T.C. Bakker Schut, J.C. den Hollander et al., Discriminating basal cell carcinoma from perilesional skin using high wave-number Raman spectroscopy. J. Biomed. Opt. 12, 034004 (2007)
J.T. Motz, S.J. Gandhi, O.R. Scepanovic, A.S. Haka, J.R. Kramer, R.R. Dasari et al., Real-time Raman system for in vivo disease diagnosis. J. Biomed. Opt. 10, 031113 (2005)
J.T. Motz, M. Fitzmaurice, A. Miller, S.J. Gandhi, A.S. Haka, L.H. Galindo et al., In vivo Raman spectral pathology of human atherosclerosis and vulnerable plaque. J. Biomed. Opt. 11, 021003 (2006)
A.S. Haka, Z. Volynskaya, J.A. Gardecki, J. Nazemi, J. Lyons, D. Hicks et al., In vivo margin assessment during partial mastectomy breast surgery using raman spectroscopy. Cancer Res. 66, 3317–3322 (2006)
K. Peremans, B. Cornelissen, B. Van Den Bossche, K. Audenaert, C. Van de Wiele, A review of small animal imaging planar and pinhole spect Gamma camera imaging. Vet. Radiol. Ultrasound. 46, 162–170 (2005)
S. Xue, C. Zhang, Y. Yang, L. Zhang, D. Cheng, J. Zhang et al., 99mTc-labeled iron oxide nanoparticles for dual-contrast (T1/T2) magnetic resonance and dual-modality imaging of tumor angiogenesis. J. Biomed. Nanotechnol. 11, 1027–1037 (2015)
E. Locatelli, M. Naddaka, C. Uboldi, G. Loudos, E. Fragogeorgi, V. Molinari et al., Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma. Nanomedicine (Lond). 9, 839–849 (2014)
E. Morales-Avila, G. Ferro-Flores, B.E. Ocampo-Garcia, L.M. De Leon-Rodriguez, C.L. Santos-Cuevas, R. Garcia-Becerra et al., Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor alpha(v)beta(3) expression. Bioconjug. Chem. 22, 913–922 (2011)
M. Tsuchimochi, K. Hayama, M. Toyama, I. Sasagawa, N. Tsubokawa, Dual-modality imaging with 99mTc and fluorescent indocyanine green using surface-modified silica nanoparticles for biopsy of the sentinel lymph node: an animal study. EJNMMI Res. 3, 33 (2013)
Y. Seo, C.M. Aparici, C.P. Chen, C. Hsu, N. Kased, C. Schreck et al., Mapping of lymphatic drainage from the prostate using filtered 99mTc-sulfur nanocolloid and SPECT/CT. J. Nucl. Med. 52, 1068–1072 (2011)
M.S. Bradbury, M. Pauliah, P. Zanzonico, U. Wiesner, S. Patel, Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 8, 535–553 (2016)
T.M. Shaffer, M.A. Wall, S. Harmsen, V.A. Longo, C.M. Drain, M.F. Kircher et al., Silica nanoparticles as substrates for chelator-free labeling of oxophilic radioisotopes. Nano Lett. 15, 864–868 (2015)
H. Zhu, J. Zhao, X. Lin, Y. Hong, C. Li, Z. Yang, Design, synthesis and evaluation of dual-modality glyco-nanoparticles for tumor imaging. Molecules 18, 6425–6438 (2013)
D. Hoffman, M. Sun, L. Yang, P.R. McDonagh, F. Corwin, G. Sundaresan et al., Intrinsically radiolabeled [59Fe]-SPIONs for dual MRI/radionuclide detection. Am. J. Nucl. Med. Mol. Imaging 4, 548–560 (2014)
A.F. Chatziioannou, Instrumentation for molecular imaging in preclinical research: micro-PET and micro-SPECT. Proc. Am. Thorac. Soc. 2(533–6), 10–11 (2005)
F. Beekman, F. van der Have, The pinhole: gateway to ultra-high-resolution three-dimensional radionuclide imaging. Eur. J. Nucl. Med. Mol. Imaging 34, 151–161 (2007)
D.S. Berman, H. Kiat, K. Van Train, J.D. Friedman, F.P. Wang, G. Germano, Dual-isotope myocardial perfusion SPECT with rest thallium-201 and stress Tc-99m sestamibi. Cardiol. Clin. 12, 261–270 (1994)
E.P. Visser, J.A. Disselhorst, M. Brom, P. Laverman, M. Gotthardt, W.J. Oyen et al., Spatial resolution and sensitivity of the Inveon small-animal PET scanner. J. Nucl. Med. 50, 139–147 (2009)
M.E. Phelps, E.J. Hoffman, N.A. Mullani, M.M. Ter-Pogossian, Application of annihilation coincidence detection to transaxial reconstruction tomography. J. Nucl. Med. 16, 210–224 (1975)
S.R. Cherry, Y. Shao, R. Silverman, K. Meadors, S. Siegel, A. Chatziioannou et al., MicroPET: a high resolution PET scanner for imaging small animals. IEEE Trans. Nucl. Sci. 44, 1161–1166 (1997)
M.E. Phelps, PET: the merging of biology and imaging into molecular imaging. J. Nucl. Med. 41, 661–681 (2000)
Z. Liu, W. Cai, L. He, N. Nakayama, K. Chen, X. Sun et al., In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2, 47–52 (2007)
V. Schulz, I. Torres-Espallardo, S. Renisch, Z. Hu, N. Ojha, P. Bornert et al., Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur. J. Nucl. Med. Mol. Imaging 38, 138–152 (2011)
M. Wiesmuller, H.H. Quick, B. Navalpakkam, M.M. Lell, M. Uder, P. Ritt et al., Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT. Eur. J. Nucl. Med. Mol. Imaging 40, 12–21 (2013)
R. Sharma, Y. Xu, S.W. Kim, M.J. Schueller, D. Alexoff, S.D. Smith et al., Carbon-11 radiolabeling of iron-oxide nanoparticles for dual-modality PET/MR imaging. Nanoscale 5, 7476–7483 (2013)
C. Perez-Campana, V. Gomez-Vallejo, M. Puigivila, A. Martin, T. Calvo-Fernandez, S.E. Moya et al., Biodistribution of different sized nanoparticles assessed by positron emission tomography: a general strategy for direct activation of metal oxide particles. ACS Nano 7, 3498–3505 (2013)
R. Madru, T.A. Tran, J. Axelsson, C. Ingvar, A. Bibic, F. Stahlberg et al., 68Ga-labeled superparamagnetic iron oxide nanoparticles (SPIONs) for multi-modality PET/MR/Cherenkov luminescence imaging of sentinel lymph nodes. Am. J. Nucl. Med. Mol. Imaging. 4, 60–69 (2013)
T.W. Liu, T.D. MacDonald, J. Shi, B.C. Wilson, G. Zheng, Intrinsically copper-64-labeled organic nanoparticles as radiotracers. Angew. Chem. Int. Ed. Engl. 51, 13128–13131 (2012)
F. Chen, S. Goel, H.F. Valdovinos, H. Luo, R. Hernandez, T.E. Barnhart et al., In vivo integrity and biological fate of chelator-free zirconium-89-labeled mesoporous silica nanoparticles. ACS Nano 9, 7950–7959 (2015)
W. Cai, K. Chen, Z.B. Li, S.S. Gambhir, X. Chen, Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature. J. Nucl. Med. 48, 1862–1870 (2007)
W. Cai, D.W. Shin, K. Chen, O. Gheysens, Q. Cao, S.X. Wang et al., Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett. 6, 669–676 (2006)
C. Kirchner, T. Liedl, S. Kudera, T. Pellegrino, A. Munoz Javier, H.E. Gaub et al., Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett. 5, 331–338 (2005)
S.W. Zielhuis, J.H. Seppenwoolde, V.A. Mateus, C.J. Bakker, G.C. Krijger, G. Storm et al., Lanthanide-loaded liposomes for multimodality imaging and therapy. Cancer Biother. Radiopharm. 21, 520–527 (2006)
Z. Medarova, W. Pham, C. Farrar, V. Petkova, A. Moore, In vivo imaging of siRNA delivery and silencing in tumors. Nat. Med. 13, 372–377 (2007)
C.C. Mello, D. Conte Jr., Revealing the world of RNA interference. Nature 431, 338–342 (2004)
A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, C.C. Mello, Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811 (1998)
M. Mae, U. Langel, Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr. Opin. Pharmacol. 6, 509–514 (2006)
H. Hong, Y. Zhang, J. Sun, W. Cai, Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today 4, 399–413 (2009)
Y.I. Kim, S. Jeong, K.O. Jung, M.G. Song, C.H. Lee, S.J. Chung et al., Simultaneous detection of EGFR and VEGF in colorectal cancer using Fluorescence-Raman Endoscopy. Sci. Rep. 7, 1035 (2017)
J.L. Houghton, B.M. Zeglis, D. Abdel-Atti, R. Aggeler, R. Sawada, B.J. Agnew et al., Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer. Proc. Natl. Acad. Sci. U.S.A. 112, 15850–15855 (2015)
Y. Xing, J. Zhao, P.S. Conti, K. Chen, Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics 4, 290–306 (2014)
D.S. Lee, H.J. Im, Y.S. Lee, Radionanomedicine: widened perspectives of molecular theragnosis. Nanomedicine 11, 795–810 (2015)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Kim, Yi., Lee, D.S. (2018). Molecular Imaging Using Radionanomedicine. In: Lee, D. (eds) Radionanomedicine. Biological and Medical Physics, Biomedical Engineering. Springer, Cham. https://doi.org/10.1007/978-3-319-67720-0_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-67720-0_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67719-4
Online ISBN: 978-3-319-67720-0
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)